State Street’s SAB Biotherapeutics SABS Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2024
Q1 | – | Sell |
-8,124
| Closed | -$55.9K | – | 4398 |
|
|
2023
Q4 | $55.9K | Hold |
8,124
| – | – | ﹤0.01% | 4177 |
|
|
2023
Q3 | $51.2K | Hold |
8,124
| – | – | ﹤0.01% | 4284 |
|
|
2023
Q2 | $67.4K | Hold |
8,124
| – | – | ﹤0.01% | 4330 |
|
|
2023
Q1 | $35.7K | Hold |
8,124
| – | – | ﹤0.01% | 4586 |
|
|
2022
Q4 | $47.9K | Hold |
8,124
| – | – | ﹤0.01% | 4567 |
|
|
2022
Q3 | $57K | Hold |
8,124
| – | – | ﹤0.01% | 4628 |
|
|
2022
Q2 | $118K | Buy |
8,124
+3,890
| +92% | +$56.5K | ﹤0.01% | 4449 |
|
|
2022
Q1 | $159K | Buy |
4,234
+3,004
| +244% | +$113K | ﹤0.01% | 4467 |
|
|
2021
Q4 | $96K | Buy |
+1,230
| New | +$96K | ﹤0.01% | 4590 |
|